Financial Sense Advisors’s Gilead Sciences GILD Stock Holding History

Financial Sense Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,000	Closed	-$231K	–	103
2020 Q2	$231K	Hold	3,000	–	–	0.08%	85
2020 Q1	$224K	Buy	+3,000	New	+$207K	0.1%	82
2019 Q3	–	Sell	-3,000	Closed	-$203K	–	80
2019 Q2	$203K	Buy	+3,000	New	+$197K	0.09%	66
2017 Q4	–	Sell	-6,010	Closed	-$487K	–	90
2017 Q3	$487K	Buy	+6,010	New	+$460K	0.25%	41

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Financial Sense Advisors's GILD Position: Q3 2020 in Review

Financial Sense Advisors sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,000 shares — an estimated $231K sold.

Financial Sense Advisors first reported a position in GILD in Q3 2017 and held it in 4 quarters. The position peaked at $487K in Q3 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Financial Sense Advisors reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Financial Sense Advisors sold 3,000 Gilead Sciences shares in Q3 2020, an estimated $231K.
Financial Sense Advisors first reported a position in Gilead Sciences in Q3 2017 and held it in 4 quarters.
Financial Sense Advisors's Gilead Sciences position peaked at $487K in Q3 2017.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Financial Sense Advisors's 13F filing for Q3 2020, filed 21 Oct 2020.